Unresolved questions in Alzheimer's research: will biomarkers help?

Biomark Med. 2014;8(1):61-3. doi: 10.2217/bmm.13.120.

Author

Henrik Zetterberg¹

Affiliation

¹ Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden and UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. henrik.zetterberg@gu.se.

PMID: 24325225
DOI: 10.2217/bmm.13.120

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Alzheimer Disease / diagnosis*
Amyloid beta-Peptides / cerebrospinal fluid
Amyloid beta-Peptides / metabolism
Biomarkers / cerebrospinal fluid
Biomarkers / metabolism*
Humans
Membrane Glycoproteins / genetics
Presenilin-1 / genetics
Receptors, Immunologic / genetics

Substances

Amyloid beta-Peptides
Biomarkers
Membrane Glycoproteins
PSEN1 protein, human
Presenilin-1
Receptors, Immunologic
TREM2 protein, human